ES2067418A1 - New application of recombinant human interleukin-1 beta in the ophthalmology field - Google Patents
New application of recombinant human interleukin-1 beta in the ophthalmology fieldInfo
- Publication number
- ES2067418A1 ES2067418A1 ES09301611A ES9301611A ES2067418A1 ES 2067418 A1 ES2067418 A1 ES 2067418A1 ES 09301611 A ES09301611 A ES 09301611A ES 9301611 A ES9301611 A ES 9301611A ES 2067418 A1 ES2067418 A1 ES 2067418A1
- Authority
- ES
- Spain
- Prior art keywords
- beta
- recombinant human
- new application
- human interleukin
- interleukin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
New application of recombinant human interleukin-1 beta in the ophthalmology field. Recombinant human interleukin-1 beta has applications as a drug for the treatment of human intravitreous haemorrhages, which are an important cause of blindness. The aforesaid interleukin also has applications in the manufacture of drugs for the treatment of said haemorrhages in the form of intravitreous injections, intended to be administered by the transconjunctival route, with an interleukin dose of 1,000 biological units at most.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9301611A ES2067418B1 (en) | 1993-07-16 | 1993-07-16 | NEW APPLICATION OF INTERLEUKINA-1 BETA RECOMBINANT HUMAN IN THE FIELD OF OPHTHALMOLOGY. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9301611A ES2067418B1 (en) | 1993-07-16 | 1993-07-16 | NEW APPLICATION OF INTERLEUKINA-1 BETA RECOMBINANT HUMAN IN THE FIELD OF OPHTHALMOLOGY. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2067418A1 true ES2067418A1 (en) | 1995-03-16 |
ES2067418B1 ES2067418B1 (en) | 1995-11-01 |
Family
ID=8282586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9301611A Expired - Fee Related ES2067418B1 (en) | 1993-07-16 | 1993-07-16 | NEW APPLICATION OF INTERLEUKINA-1 BETA RECOMBINANT HUMAN IN THE FIELD OF OPHTHALMOLOGY. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2067418B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004054589A1 (en) * | 2002-12-13 | 2004-07-01 | Arturo Jimenez Bayardo | Intravitreally-injectable solution for the treatment of vitreous haemorrhages |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007932A1 (en) * | 1989-01-20 | 1990-07-26 | The University Of Melbourne | Fibrinolysis |
WO1990012590A1 (en) * | 1989-04-14 | 1990-11-01 | State Of Oregon, State Board Of Higher Education, Oregon Health Sciences University | Treatment of ocular disease by modulation of matrix metalloproteinases and their inhibitor |
-
1993
- 1993-07-16 ES ES9301611A patent/ES2067418B1/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990007932A1 (en) * | 1989-01-20 | 1990-07-26 | The University Of Melbourne | Fibrinolysis |
WO1990012590A1 (en) * | 1989-04-14 | 1990-11-01 | State Of Oregon, State Board Of Higher Education, Oregon Health Sciences University | Treatment of ocular disease by modulation of matrix metalloproteinases and their inhibitor |
Non-Patent Citations (1)
Title |
---|
OPHTALMIC RESEARCH, Vol. 25 (5), 1993; J.C. PASTOR y C. FERNANDEZ: "Efficacy of intravenous interleukin-1 in the reabsortion of experimental vitreous hemorrhage in rabbits" pßg. 3302-3306 * Todo el documento * * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004054589A1 (en) * | 2002-12-13 | 2004-07-01 | Arturo Jimenez Bayardo | Intravitreally-injectable solution for the treatment of vitreous haemorrhages |
Also Published As
Publication number | Publication date |
---|---|
ES2067418B1 (en) | 1995-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69333321T2 (en) | Use of a consensus interferon to reduce the side effects in the interferon treatment of viral hepatites. | |
PT693924E (en) | PROCESSES FOR THE ADMINISTRATION (IN VIVO) OF BIOLOGICAL AND COMPOSITION SUBSTANCES USED IN THESE PROCESSES | |
CA2114014A1 (en) | Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine | |
IL87621A0 (en) | Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them | |
ATE515265T1 (en) | VITAMIN D AND ITS ANALOGUES FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISEASES | |
CA2031430A1 (en) | Process for refolding recombinantly produced tgf-.beta.-like proteins | |
ES2177780T3 (en) | MEDICATIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES USING INTERFERON TAU. | |
AU7405387A (en) | Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof | |
DE69628163D1 (en) | NOR-PREGNANE FOR INDUCING HYPOTHALAMIC EFFECTS | |
MY102918A (en) | Purified antineoplaston fractions and methods of treating neoplastic disease. | |
NZ335003A (en) | Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1) | |
ZA87472B (en) | System for delivering drug with enhanced bioacceptability | |
KR910700069A (en) | Treatment of Leukocyte Dysfunction Using GM-CSF | |
ES2067418A1 (en) | New application of recombinant human interleukin-1 beta in the ophthalmology field | |
EA200200801A1 (en) | Use of follicle-stimulating hormone (FSH) for the treatment of infertility | |
ATE222768T1 (en) | CTLA-8 IN COMBINATION WITH G-CSF OR WITH G-CSF AND IL-6, AND USE OF CTLA-8 TO TREAT INFECTIONS | |
KR900701311A (en) | How to treat squamous cell carcinoma by administering recombinant human α-interferon intralesionally | |
AU2229997A (en) | Pharmaceutical compositions comprising natural human alpha-interferon | |
KR920014480A (en) | Use of a polypeptide having activity of human interleukin 2 to prepare a pharmaceutical composition for treating pneumothorax | |
WO2004006950A2 (en) | Use of cd152 for treating autoimmune diseases and inflammations | |
MY119359A (en) | Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD2A | Announcement of lapse in spain |
Effective date: 20141120 |